Join us at the 2nd International Conference on Hemophilia and Rare Bleeding Disorder, in partnership with the World Federation of Hemophilia, taking place on October 7-8, 2023, at the prestigious Grand Hyatt Hotel in Abu Dhabi, UAE.

This exceptional conference, organized by the scientific and organizing committees, aims to showcase the latest advancements, exchange cutting-edge scientific research, and discuss the newest clinical applications in the field of Hemophilia and rare bleeding disorders. Focusing on improving care and treatment for patients in the UAE and the surrounding region, the comprehensive two-day program has been carefully curated by the scientific committee to address the current challenges and developments in this area.

Read on go.evvnt.com

Scripps MD Anderson Cancer Center's Annual Cancer Care Symposium is designed for nurses, nurse practitioners, physician assistants, clinical nurse specialists, and other health care professionals who treat cancer patients. During this two-day conference, participants will hear from expert faculty representing practice settings across the continuum of care as they discuss clinical developments and treatment advances in hematology and oncology. The 2023 symposium will provide important updates in onco-fertility, palliative care, advances in surgical oncology, pharmacology, cancer in transgender and gender-diverse populations and post-covid implications for cancer patients, as well as new treatments for various malignancies.

Read on go.evvnt.com

The 4th International Conference on Lymphocyte Engineering (ICLE 2023) will take place on 12-14 September 2023 in Munich, Germany.

ICLE is a cornerstone conference for the latest advances in immune-gene therapy, where ground-breaking research in the field is presented along with innovative clinical practices and treatment. Join the 2023 edition as it brings together immunotherapy with cell and gene therapy to foster interdisciplinary collaborations, deepening the connection between basic and clinical research across related disease specialties.

ICLE 2023 will once again take place in Munich - home to the biggest European research hub in the field, the perfect location for the only international conference focusing specifically on research and clinical translation of gene therapy, cell therapy, genome engineering, and immunotherapy.

Great strides have been made in recent years in the engineering of lymphocytes for the treatment of cancer, autoimmune diseases, pathogenic diseases, and primary immune deficiencies. Combining gene therapy, cell therapy and immune therapy, the emerging field of lymphocyte engineering employs cutting-edge technologies of viral and non-viral vectorology, genome editing, and protein design as well as advanced clinical protocols for cell harvest, expansion, and re-infusion and for the exciting alternative of in vivo engineering. With groundbreaking clinical success leading to FDA-approved products and with vibrant, exponentially growing research, lymphocyte engineering is the wave of the future.

Still, the challenges are formidable, and the stakes are high. Realizing the full promise of lymphocyte engineering will require the combined efforts of a dedicated community. ICLE 2023 will facilitate the sharing of data and ideas, promote collaborations, and address common challenges to advance clinical translation. It will provide an effective environment for active learning, discussions of real-world case studies, and networking between like-minded peers. Learn what is done to translate the lymphocyte engineering research to clinical practice and how your colleagues overcome their challenges. Hear from renown leaders, sharing invaluable insights on lymphocyte engineering therapies and discuss the latest findings and trends.

Whether you are a scientist, clinical researcher, part of a start-up, or an established industry company, ICLE 2023 is your opportunity to network and discuss immuno-gene therapy with those as excited and passionate about this innovative treatment modality.

Read on kenes.com

This conference is for both General Pediatricians and Pediatric Hematologists and Oncologists. We aim to emphasize on the early detection and diagnosis of common hematological and oncological problems in children and to discuss their management by both the general practitioner and the specialist.

We are delighted to present renowned experts from the UAE and abroad. The focus will be on interaction and exchange of ideas, knowledge and experience that will enable best possible care for children. We believe the event will be of interest to General Pediatricians, Pediatric Subspecialists, Pediatric Trainees, Residents and Fellows, Family Physicians, General Practitioners, and Emergency Medicine Physicians.

The event will also provide an opportunity for networking for future academic and clinical collaborations. we look forward to your participation and trust this will be a unique educational experience.

Read on menaconference.com